These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


414 related items for PubMed ID: 19751275

  • 21. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A, Murakami Y, Kitasato H, Hayashi I, Endo H.
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [Abstract] [Full Text] [Related]

  • 22. The anionic amphiphile SDS is an antagonist for the human neutrophil formyl peptide receptor 1.
    Thorén FB, Karlsson J, Dahlgren C, Forsman H.
    Biochem Pharmacol; 2010 Aug 01; 80(3):389-95. PubMed ID: 20394736
    [Abstract] [Full Text] [Related]

  • 23. A novel nonpeptide ligand for formyl peptide receptor-like 1.
    Nanamori M, Cheng X, Mei J, Sang H, Xuan Y, Zhou C, Wang MW, Ye RD.
    Mol Pharmacol; 2004 Nov 01; 66(5):1213-22. PubMed ID: 15308762
    [Abstract] [Full Text] [Related]

  • 24. Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils.
    Sullivan GW, Lee DD, Ross WG, DiVietro JA, Lappas CM, Lawrence MB, Linden J.
    J Leukoc Biol; 2004 Jan 01; 75(1):127-34. PubMed ID: 14525968
    [Abstract] [Full Text] [Related]

  • 25. Proinflammatory activity of a cecropin-like antibacterial peptide from Helicobacter pylori.
    Bylund J, Christophe T, Boulay F, Nyström T, Karlsson A, Dahlgren C.
    Antimicrob Agents Chemother; 2001 Jun 01; 45(6):1700-4. PubMed ID: 11353614
    [Abstract] [Full Text] [Related]

  • 26. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
    Sordi R, Menezes-de-Lima O, Horewicz V, Scheschowitsch K, Santos LF, Assreuy J.
    Int Immunopharmacol; 2013 Oct 01; 17(2):283-92. PubMed ID: 23816538
    [Abstract] [Full Text] [Related]

  • 27. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
    Maaty WS, Lord CI, Gripentrog JM, Riesselman M, Keren-Aviram G, Liu T, Dratz EA, Bothner B, Jesaitis AJ.
    J Biol Chem; 2013 Sep 20; 288(38):27042-27058. PubMed ID: 23873933
    [Abstract] [Full Text] [Related]

  • 28. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1.
    Björkman L, Karlsson J, Karlsson A, Rabiet MJ, Boulay F, Fu H, Bylund J, Dahlgren C.
    J Leukoc Biol; 2008 Feb 20; 83(2):245-53. PubMed ID: 17984291
    [Abstract] [Full Text] [Related]

  • 29. Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects.
    Conte FP, Menezes-de-Lima O, Verri WA, Cunha FQ, Penido C, Henriques MG.
    Br J Pharmacol; 2010 Oct 20; 161(4):911-24. PubMed ID: 20860668
    [Abstract] [Full Text] [Related]

  • 30. Histamine inhibits neutrophil NADPH oxidase activity triggered by the lipoxin A4 receptor-specific peptide agonist Trp-Lys-Tyr-Met-Val-Met.
    Betten A, Dahlgren C, Hermodsson S, Hellstrand K.
    Scand J Immunol; 2003 Sep 20; 58(3):321-6. PubMed ID: 12950678
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells.
    Bonnans C, Gras D, Chavis C, Mainprice B, Vachier I, Godard P, Chanez P.
    Biomed Pharmacother; 2007 Jun 20; 61(5):261-7. PubMed ID: 17418999
    [Abstract] [Full Text] [Related]

  • 32. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
    Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, Perretti M.
    J Immunol; 2011 Apr 15; 186(8):4905-14. PubMed ID: 21398608
    [Abstract] [Full Text] [Related]

  • 33. A methodological approach to studies of desensitization of the formyl peptide receptor: Role of the read out system, reactive oxygen species and the specific agonist used to trigger neutrophils.
    Karlsson J, Bylund J, Movitz C, Björkman L, Forsman H, Dahlgren C.
    J Immunol Methods; 2010 Jan 31; 352(1-2):45-53. PubMed ID: 19891970
    [Abstract] [Full Text] [Related]

  • 34. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
    Cevik-Aras H, Kalderén C, Jenmalm Jensen A, Oprea T, Dahlgren C, Forsman H.
    Biochem Pharmacol; 2012 Jun 15; 83(12):1655-62. PubMed ID: 22410002
    [Abstract] [Full Text] [Related]

  • 35. Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response.
    Wittmann S, Rothe G, Schmitz G, Fröhlich D.
    Cytometry A; 2004 Jan 15; 57(1):53-62. PubMed ID: 14699606
    [Abstract] [Full Text] [Related]

  • 36. Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949.
    Lind S, Sundqvist M, Holmdahl R, Dahlgren C, Forsman H, Olofsson P.
    Biochem Pharmacol; 2019 Aug 15; 166():163-173. PubMed ID: 31085160
    [Abstract] [Full Text] [Related]

  • 37. Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.
    Chinthamani S, Odusanwo O, Mondal N, Nelson J, Neelamegham S, Baker OJ.
    Am J Physiol Cell Physiol; 2012 Apr 01; 302(7):C968-78. PubMed ID: 22205391
    [Abstract] [Full Text] [Related]

  • 38. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4.
    Christophe T, Karlsson A, Rabiet MJ, Boulay F, Dahlgren C.
    Scand J Immunol; 2002 Nov 01; 56(5):470-6. PubMed ID: 12410796
    [Abstract] [Full Text] [Related]

  • 39. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.
    Medeiros R, Rodrigues GB, Figueiredo CP, Rodrigues EB, Grumman A, Menezes-de-Lima O, Passos GF, Calixto JB.
    Mol Pharmacol; 2008 Jul 01; 74(1):154-61. PubMed ID: 18413658
    [Abstract] [Full Text] [Related]

  • 40. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
    Liu FC, Yu HP, Syu YT, Fang JY, Lin CF, Chang SH, Lee YT, Hwang TL.
    Sci Rep; 2017 Jul 27; 7(1):6718. PubMed ID: 28751674
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.